摘要
美国糖尿病学会(American Diabetes Association,ADA)与欧洲糖尿病研究学会(European Association for the Study of Diabetes,EASD)在2022年8月更新发布了《2型糖尿病患者的血糖管理》共识。本共识基于最新的循证学依据对文献进行系统性回顾,提出15条专家推荐以及9条实操要点,结合流程图,对成人非妊娠2型糖尿病的血糖管理进行阐述、修订与内容增补,重点强调了身体活动行为干预(包括睡眠)、体重管理以及降糖药的选择。其中,重新审视了胰岛素在血糖管理中的地位,更新了钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂的心肾保护证据。
The American Diabetes Association(ADA)/European Association for the Study of Diabetes(EASD)updated and published the consensus report on August 8,2022.The new consensus made a systematic review of the literature,proposing 15 expert recommendations and 9 practical points combined with flow charts to standardize the management of hyperglycemia in non-pregnant adults with type 2 diabetes.The consensus report stressed the importance of physical activity behaviors(including sleep),weight management,and the choice of hypoglycemic agents.It also revisits the place of insulin in hyperglycemia management and updates the evidence for cardiorenal protective effects of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists.
作者
张瑞祥
黄文彬
韦晓
刘超
Zhang Ruixiang;Huang Wenbin;Wei Xiao;Liu Chao(Endocrine and Diabetes Center,Jiangsu Province Hospital on Integration of Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Jiangsu Branch of China Academy of Chinese Medical Science,Nanjing 210028,China)
出处
《国际内分泌代谢杂志》
2024年第4期264-268,共5页
International Journal of Endocrinology and Metabolism
关键词
2型糖尿病
心肾保护
减重
Type 2 diabetes mellitus
Cardiorenal protection
Weight loss